New Delhi: Covaxin, produced by Hyderabad-based Bharat Biotech, is likely to be approved by the World Health Organisation (WHO). On Tuesday, the vaccine was reviewed by a technical committee of the WHO.
Speaking to the press, an official of WHO Dr Margaret Harris said, "On Covaxin, the technical advisory group that reviews all the data for a potential emergency use listing are indeed reviewing that data today. Now if all is in place, and all goes well, and if the committee is satisfied, we would expect a recommendation within the next 24 hours or so."
Bharat Biotech had submitted an Expression of Interest (EOI) for Covaxin to the WHO on April 19 for Emergency Use Listing (EUL). Initially, the WHO had said that the vaccine must be thoroughly evaluated to ensure that it is "safe and effective" for use.
After much delay in the approval of the vaccine, the WHO responded by saying that it "cannot cut corners".
The approval of the vaccine will bring great relief to the citizens of India who have been administered doses of the same as it will make them eligible for international travel.
As per the international travel guidelines, it has been mandatory for travellers to provide vaccination certificates for vaccines approved by WHO.
The data of the Covaxin is being submitted by the Bharat Biotech to the WHO who have been reviewing the same in a spontaneous manner.